In hepatocellular carcinoma HepG2 cells, it enhances the expression of miR-497-5p, which can target the 3′-UTR of the cyclin-dependent kinase 4 (CDK4) mRNA, leading to decreased levels of this kinase and increased cell proliferation [21] (Table 1). The gene discussed is CDK4; the disease is hepatocellular carcinoma.